US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Tracks Biotherapeutics Inc

32.01

+1.424.64%

Post-market: 32.010.00000.00%19:34 EDT

Volume:1.48M

Turnover:47.28M

Market Cap:1.14B

PE:-7.07

High:33.31

Open:33.31

Low:30.11

Close:30.59

52wk High:49.91

52wk Low:14.72

Shares:35.73M

Float Shares:34.75M

Volume Ratio:2.20

T/O Rate:4.27%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.5296

ROE:-48.91%

ROA:-28.97%

PB:6.78

PE(LYR):- -

Loading ...

Overview Company News Filings

First Tracks Biotherapeutics Inc : Canaccord Genuity Initiates Coverage with Buy Rating; Target Price $50

THOMSON REUTERS

Canaccord Genuity Initiates First Tracks Biotherapeutics at Buy With $50 Price Target

MT Newswires Live

First Tracks Biotherap Initiated at Outperform by Evercore ISI Group

First Tracks Biotherapeutics initiated with an Outperform at Evercore ISI

Guggenheim Initiates First Tracks Biotherapeutics at Buy

MT Newswires Live

First Tracks Biotherapeutics Director Ware J. Anthony Sells 39,265 Shares Worth $1.76 Million

First Tracks Biotherap Price Target Maintained with a $57.00/Share by HC Wainwright & Co.

Analyst Reiterates Buy on TRAX as IL-15/CD122 Data De-Risk Celiac Program; $57 Price Target Maintained

First Tracks Biotherapeutics Inc (TRAX) Receives a Rating Update from a Top Analyst

Piper Sandler Sticks to Its Buy Rating for First Tracks Biotherapeutics Inc (TRAX)

First Tracks Biotherapeutics to Join Wells Fargo Healthcare Conference Fireside Chat

Analysts Offer Insights on NA Companies: Arcturus Therapeutics (ARCT), EquipmentShare.com, Inc. (EQPT) and First Tracks Biotherapeutics Inc (TRAX)

First Tracks Biotherapeutics Inc : JP Morgan Raises Target Price to $65 from $30

THOMSON REUTERS

First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Results

Benzinga Earnings

First Tracks Biotherap Price Target Raised to $57.00/Share from $44.00 by HC Wainwright & Co.

Barclays Sticks to Its Buy Rating for First Tracks Biotherapeutics Inc (TRAX)

First Tracks Biotherapeutics Inc : Piper Sandler Raises Target Price to $95 from $54

THOMSON REUTERS

First Tracks Q2 EPS $(0.95) Up From $(1.47) YoY

Benzinga Earnings

First Tracks Q2 FY26 Net Loss Narrows to $33.37 Million

Press Release: First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/TRAX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRAX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAX\",,,,,undefined,":{"symbol":"TRAX","market":"US","secType":"STK","nameCN":"First Tracks Biotherapeutics Inc","latestPrice":32.01,"timestamp":1791489600000,"preClose":30.59,"halted":0,"volume":1483448,"hourTrading":{"tag":"盘后","latestPrice":32.01,"preClose":32.01,"latestTime":"19:34 EDT","volume":78028,"amount":2497643.9095,"timestamp":1791502441473,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.046420398823144755,"floatShares":34748800,"shares":35730843,"eps":-4.529554,"marketStatus":"Closed","change":1.42,"latestTime":"10-08 16:00:00 EDT","open":33.31,"high":33.31,"low":30.11,"amount":47283357.763736,"amplitude":0.104609,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.529554,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791532800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":30.59,"preHourTrading":{"tag":"盘前","latestPrice":32.45,"preClose":30.59,"latestTime":"09:29 EDT","volume":38984,"amount":1275609.1084,"timestamp":1791466199982,"change":1.86,"changeRate":0.060804,"amplitude":0.188349},"postHourTrading":{"tag":"盘后","latestPrice":32.01,"preClose":32.01,"latestTime":"19:34 EDT","volume":78028,"amount":2497643.9095,"timestamp":1791502441473,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.201305,"impliedVol":0.9312,"impliedVolPercentile":0.619},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAX\",,,,,undefined,":{"symbol":"TRAX","floatShares":34748800,"roa":"-28.97%","roe":"-48.91%","lyrEps":0,"volumeRatio":2.201305,"shares":35730843,"dividePrice":0,"high":33.31,"amplitude":0.104609,"preClose":30.59,"low":30.11,"week52Low":14.72,"pbRate":"6.78","week52High":49.9114,"institutionHeld":0,"latestPrice":32.01,"eps":-4.529554,"divideRate":0,"volume":1483448,"delay":0,"ttmEps":-4.529554,"open":33.31,"prevYearClose":20,"prevWeekClose":33.28,"prevMonthClose":35.44,"prevQuarterClose":35.44,"fiveDayClose":33.92,"twentyDayClose":37.98,"sixtyDayClose":36.13},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRAX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"TRAX","fiscalQuarterEnding":"2026/06","expectedEps":-0.74,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.95}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRAX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRAX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":12,"updateTime":1790827200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRAX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRAX","date":"2026-10-07","current":-7.066921,"percent":0.530973,"low":-10.141689,"twenty":-9.327679,"median":-7.385601,"eighty":-3.651263,"high":-3.156022,"avg":-6.449183,"sd":2.582485,"marketCap":1121591161},"quantilePoints":[{"date":"2026-04-24","current":-3.975194,"twenty":-3.975194,"median":-3.975194,"eighty":-3.975194,"marketCap":660227979},{"date":"2026-05-01","current":-4.868566,"twenty":-4.868566,"median":-4.085034,"eighty":-3.799448,"marketCap":808605530},{"date":"2026-05-08","current":-3.728313,"twenty":-4.68236,"median":-4.236719,"eighty":-3.799448,"marketCap":619224346},{"date":"2026-05-15","current":-3.799448,"twenty":-4.433387,"median":-4.031683,"eighty":-3.799448,"marketCap":631038952},{"date":"2026-05-22","current":-3.452672,"twenty":-4.299486,"median":-3.855938,"eighty":-3.664859,"marketCap":584796305},{"date":"2026-05-29","current":-3.259026,"twenty":-4.249272,"median":-3.799448,"eighty":-3.475745,"marketCap":551997467},{"date":"2026-06-05","current":-3.749322,"twenty":-4.203244,"median":-3.738817,"eighty":-3.411676,"marketCap":635041334},{"date":"2026-06-12","current":-3.508294,"twenty":-4.109513,"median":-3.726221,"eighty":-3.329068,"marketCap":594217248},{"date":"2026-06-18","current":-3.743141,"twenty":-4.020386,"median":-3.683399,"eighty":-3.361617,"marketCap":633994562},{"date":"2026-06-26","current":-3.372329,"twenty":-3.945066,"median":-3.663829,"eighty":-3.37851,"marketCap":571188276},{"date":"2026-07-02","current":-3.829664,"twenty":-3.955109,"median":-3.663829,"eighty":-3.376449,"marketCap":648649362},{"date":"2026-07-10","current":-6.674616,"twenty":-4.112294,"median":-3.726221,"eighty":-3.397462,"marketCap":1130513144},{"date":"2026-07-17","current":-7.459502,"twenty":-4.261943,"median":-3.735727,"eighty":-3.424655,"marketCap":1263453116},{"date":"2026-07-24","current":-7.754091,"twenty":-4.794084,"median":-3.774042,"eighty":-3.434543,"marketCap":1313349220},{"date":"2026-07-31","current":-9.842999,"twenty":-6.999282,"median":-3.799448,"eighty":-3.441135,"marketCap":1667157964},{"date":"2026-08-07","current":-9.334163,"twenty":-7.464446,"median":-3.842801,"eighty":-3.45844,"marketCap":1580973783},{"date":"2026-08-14","current":-9.814035,"twenty":-7.742967,"median":-3.975194,"eighty":-3.486045,"marketCap":1573229017},{"date":"2026-08-21","current":-9.33927,"twenty":-8.651869,"median":-4.081492,"eighty":-3.504998,"marketCap":1497122321},{"date":"2026-08-28","current":-9.97229,"twenty":-9.339073,"median":-4.144854,"eighty":-3.509324,"marketCap":1598597915},{"date":"2026-09-04","current":-9.475235,"twenty":-9.448042,"median":-4.257739,"eighty":-3.516946,"marketCap":1518918135},{"date":"2026-09-11","current":-8.465524,"twenty":-9.33927,"median":-4.366436,"eighty":-3.530954,"marketCap":1357057417},{"date":"2026-09-18","current":-8.737455,"twenty":-9.338283,"median":-4.868566,"eighty":-3.539195,"marketCap":1400649045},{"date":"2026-09-25","current":-7.986302,"twenty":-9.334163,"median":-6.877533,"eighty":-3.588636,"marketCap":1280236104},{"date":"2026-10-02","current":-7.560574,"twenty":-9.330354,"median":-7.443021,"eighty":-3.633958,"marketCap":1211990194},{"date":"2026-10-07","current":-6.996651,"twenty":-9.327679,"median":-7.385601,"eighty":-3.651263,"marketCap":1121591161}],"updateTime":1791505059200},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRAX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671047702","title":"First Tracks Biotherapeutics Inc : Canaccord Genuity Initiates Coverage with Buy Rating; Target Price $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2671047702","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671047702?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:43","pubTimestamp":1790772233,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nFWN45M0XQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671208584","title":"Canaccord Genuity Initiates First Tracks Biotherapeutics at Buy With $50 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2671208584","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671208584?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:55","pubTimestamp":1790762141,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics (TRAX) has an average rating of buy and mean price target of $70, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668479179","title":"First Tracks Biotherap Initiated at Outperform by Evercore ISI Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2668479179","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668479179?lang=en_us&edition=fundamental","pubTime":"2026-09-18 18:29","pubTimestamp":1789727340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668947596","title":"First Tracks Biotherapeutics initiated with an Outperform at Evercore ISI","url":"https://stock-news.laohu8.com/highlight/detail?id=2668947596","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668947596?lang=en_us&edition=fundamental","pubTime":"2026-09-18 18:05","pubTimestamp":1789725919,"startTime":"0","endTime":"0","summary":"Evercore ISI initiated coverage of First Tracks Biotherapeutics (TRAX) with an Outperform rating and $65 price target The firm sees a “very high” p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/first-tracks-biotherapeutics-initiated-with-an-outperform-at-evercore-isi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/first-tracks-biotherapeutics-initiated-with-an-outperform-at-evercore-isi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667413602","title":"Guggenheim Initiates First Tracks Biotherapeutics at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667413602","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667413602?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:28","pubTimestamp":1789554500,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics (TRAX) has an average rating of buy and mean price target of $72.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665518733","title":"First Tracks Biotherapeutics Director Ware J. Anthony Sells 39,265 Shares Worth $1.76 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2665518733","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665518733?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:26","pubTimestamp":1788553584,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics director Ware J. Anthony sells 39,265 shares worth $1.76 millionDirector Ware J. Anthony sold 39,265 shares of First Tracks Biotherapeutics common stock on Sep. 2, 2026 at","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL6QkCmS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"First Tracks Biotherapeutics Director Ware J. Anthony Sells 39,265 Shares Worth $1.76 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664719138","title":"First Tracks Biotherap Price Target Maintained with a $57.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2664719138","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664719138?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:54","pubTimestamp":1788436440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664875485","title":"Analyst Reiterates Buy on TRAX as IL-15/CD122 Data De-Risk Celiac Program; $57 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2664875485","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664875485?lang=en_us&edition=fundamental","pubTime":"2026-09-03 18:15","pubTimestamp":1788430541,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on First Tracks Biotherapeutics Inc today and set a price target of $57.00. Emily Bodn...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-trax-as-il-15-cd122-data-de-risk-celiac-program-57-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-reiterates-buy-on-trax-as-il-15-cd122-data-de-risk-celiac-program-57-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664820584","title":"First Tracks Biotherapeutics Inc (TRAX) Receives a Rating Update from a Top Analyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2664820584","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664820584?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:36","pubTimestamp":1788424591,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout maintained a Buy rating on First Tracks Biotherapeutics Inc today and set a price target of $65.00. According to TipR...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/first-tracks-biotherapeutics-inc-trax-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/first-tracks-biotherapeutics-inc-trax-receives-a-rating-update-from-a-top-analyst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662023627","title":"Piper Sandler Sticks to Its Buy Rating for First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662023627","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662023627?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:56","pubTimestamp":1787831774,"startTime":"0","endTime":"0","summary":"In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on First Tracks Biotherapeutics Inc, with a price target of $...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-its-buy-rating-for-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662658744","title":"First Tracks Biotherapeutics to Join Wells Fargo Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2662658744","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662658744?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:18","pubTimestamp":1787775501,"startTime":"0","endTime":"0","summary":"First Tracks Biotherapeutics to join Wells Fargo Healthcare Conference fireside chatFirst Tracks Biotherapeutics will join the Wells Fargo Healthcare Conference in Boston on Sept. 9, 2026, with a 9:30","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL40fj87:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660893052","title":"Analysts Offer Insights on NA Companies: Arcturus Therapeutics (ARCT), EquipmentShare.com, Inc. (EQPT) and First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660893052","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660893052?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:20","pubTimestamp":1787224836,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the NA sector with new ratings on Arcturus Therapeutics (ARCT), EquipmentShare.com, Inc. (EQPT) and First T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-arcturus-therapeutics-arct-equipmentshare-com-inc-eqpt-and-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-arcturus-therapeutics-arct-equipmentshare-com-inc-eqpt-and-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EQPT","NA","BK4141","TRAX","ARCT","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660279495","title":"First Tracks Biotherapeutics Inc : JP Morgan Raises Target Price to $65 from $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2660279495","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660279495?lang=en_us&edition=fundamental","pubTime":"2026-08-18 23:33","pubTimestamp":1787067181,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F0OV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659415767","title":"First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659415767","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659415767?lang=en_us&edition=fundamental","pubTime":"2026-08-13 21:07","pubTimestamp":1786626443,"startTime":"0","endTime":"0","summary":"TRAX reported narrower Q2 loss of 95 cents per share. Analysts raised price targets for the stock, citing potential for ANB033 in immune diseases.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/08/61173753/first-tracks-biotherapeutics-analysts-increase-their-forecasts-after-q2-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659155006","title":"First Tracks Biotherap Price Target Raised to $57.00/Share from $44.00 by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2659155006","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659155006?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:59","pubTimestamp":1786618740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAX/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659013203","title":"Barclays Sticks to Its Buy Rating for First Tracks Biotherapeutics Inc (TRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659013203","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659013203?lang=en_us&edition=fundamental","pubTime":"2026-08-13 16:25","pubTimestamp":1786609539,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout maintained a Buy rating on First Tracks Biotherapeutics Inc today and set a price target of $65.00. Darout covers the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-first-tracks-biotherapeutics-inc-trax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659839180","title":"First Tracks Biotherapeutics Inc : Piper Sandler Raises Target Price to $95 from $54","url":"https://stock-news.laohu8.com/highlight/detail?id=2659839180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659839180?lang=en_us&edition=fundamental","pubTime":"2026-08-13 11:37","pubTimestamp":1786592223,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN4491AL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659513188","title":"First Tracks Q2 EPS $(0.95) Up From $(1.47) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2659513188","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659513188?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:38","pubTimestamp":1786567120,"startTime":"0","endTime":"0","summary":"First Tracks (NASDAQ:TRAX) reported quarterly losses of $(0.95) per share. This is a 35.37 percent increase over losses of $(1.47) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61160312/first-tracks-q2-eps-0-95-1-47-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"First Tracks Q2 EPS $(0.95) Up From $(1.47) YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSQ","QID","GPIQ","QDTE","QYLG","BK4139","QQQJ","TQQQ","SQQQ","TECS","FTEC","NDX","QQQM","JEPQ","QQQE","NVIW.SI","QLD","QQQA","TRAX","IYW","NQmain","MNQmain","QQQ","TQQY",".IXIC","QQQY","ONEQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659918900","title":"First Tracks Q2 FY26 Net Loss Narrows to $33.37 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659918900","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659918900?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:18","pubTimestamp":1786565937,"startTime":"0","endTime":"0","summary":"First Tracks Q2 FY26 net loss narrows to $33.37 millionFirst Tracks posted a Q2 net loss of $33.4 million, narrowing 21.36% from a $42.4 million loss a year earlier.Loss per share improved to $0.95 fr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL7xKFl0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAX","LU2210149790.SGD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00BN0W2W23.USD","SG9999014013.SGD","LU2095319765.USD","SG9999014021.USD","BK4588","BK4585","IE00B3QW5Z07.USD","BCDF","IE00BN0W2V16.EUR","NDAQ","IE00B64PRP62.GBP","LU0314104364.USD","LU2210150020.SGD","SG9999014005.SGD","BK4139","SG9999014039.USD","BK4112","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659009089","title":"Press Release: First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659009089","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659009089?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:15","pubTimestamp":1786565700,"startTime":"0","endTime":"0","summary":"-- Completed enrollment for Cohort 1  of Phase 1b ANB033. trial in celiac disease ; top-line Cohort 1 data reaffirmed for Q4. -- Cohort 2  enhanced to enroll up to 40 patients including. those with a broad range of histologic  and symptom. severity to further inform future development; top-line Cohort 2 data. -- U.S. FDA granted Fast Track designation for ANB033 for the treatment of. -- Enrollment ongoing for Phase 1b ANB033 trial in eosinophilic esophagitis. -- Reiterating cash-runway into Q2 2028, including the expansion of ANB033. -- U.S. FDA granted Fast Track designation to ANB033 for the. treatment of people with CeD on a gluten-free diet. -- 70-patient trial assessing one dose level of subcutaneously. -- Cohort 1  is a gluten-challenge study to assess the. -- Cohort 2  assesses the possibility of mucosal healing","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4077","TRAX","RA","BK4139","SLE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":64,"code":"91000000","status":"200"}]}}